Fundraising Fox
The ARCH Venture Partners Mafia
19 people came through ARCH Venture Partners and went on to found or lead other companies.
Richard HeymanVenture PartnerFounded Aragon Pharmaceuticals +3Robert NelsenCo-founder & Managing DirectorFounded RIPPL Care +2Sean KendallPartner (Europe)Founded ロゴマーク：AIRNA +2Keith LendenVenture PartnerFounded Boundless Bio +2Jay ParrishVenture PartnerFounded ROME Therapeutics +1Inca ComanVenture Partner, Ph.D.Founded RIPPL Care +1Axel BouchonVenture Partner, Ph.D.Founded Matter Neuroscience +1Jonathan LimVenture PartnerFounded Boundless Bio +1Sabah OneyVenture PartnerFounded Vilya +1Nathaniel E. DavidVenture PartnerFounded Unity Biotechnology +1Kristina BurowManaging DirectorFounded Neumora TherapeuticsPaul BernsManaging DirectorFounded Neumora TherapeuticsCarol SuhPartnerFounded Orbital TherapeuticsGeorge ScangosVenture Partner, Ph.D.Founded Rezo TherapeuticsNilay ThakarPrincipalFounded Skylark BioJohn MaraganoreVenture PartnerFounded Alnylam PharmaceuticalsStephanie WisnerAnalystFounded CentivaxJohn EvansVenture PartnerFounded Beam TherapeuticsMark C. McKennaVenture PartnerFounded Mirador Therapeutics
Frequently asked questions
- What is the ARCH Venture Partners mafia?
- The ARCH Venture Partners mafia is the network of 19 people who came through ARCH Venture Partners and went on to found or lead other companies, including Aragon Pharmaceuticals, RIPPL Care, ロゴマーク：AIRNA, Boundless Bio, ROME Therapeutics.
- Who is in the ARCH Venture Partners mafia?
- Notable members include Richard Heyman (Aragon Pharmaceuticals), Robert Nelsen (RIPPL Care), Sean Kendall (ロゴマーク：AIRNA), Keith Lenden (Boundless Bio), Jay Parrish (ROME Therapeutics), Inca Coman (RIPPL Care), Axel Bouchon (Matter Neuroscience), Jonathan Lim (Boundless Bio), among 19 tracked members.
- What companies did ARCH Venture Partners alumni found?
- Companies founded by ARCH Venture Partners alumni include Aragon Pharmaceuticals, RIPPL Care, ロゴマーク：AIRNA, Boundless Bio, ROME Therapeutics, Matter Neuroscience, Vilya, Unity Biotechnology, Neumora Therapeutics, Orbital Therapeutics.